Artugen Therapeutics Ltd.

University College Cork

Teagasc, the Agriculture and Food Development Authority

Mary Rea

Paul Ross

Colin Hill

Ronald Farquhar

Michelle O'Donnell

Brian Healy

Laurent Chesnel

Christopher K Murphy

Disclosed herein are compositions and methods for preventing, ameliorating, or treatinginfections and/or reducing the severity of one or more risk factors, signs, or symptoms associated withinfections. In particular, the technology of the present disclosure relates to methods for administering an effective amount of a composition comprising strains ofbacteria identified as ART24, ART4, and ART 12, to a subject suffering from or at risk forinfections.

Methods and compositions for the treatment of C. difficile

Disclosed herein are compositions and methods for preventing, ameliorating, or treatinginfections and/or reducing the severity of one or more risk factors, signs, or symptoms associated withbacteria identified as ART24, ART4, and ART 12, to a subject suffering from or at risk forinfections.

The present invention relates to a new bacteriocin, to microbial strains which can produce it and to uses of the bacteriocin and the strains. The bacteriocin is effective againstandamongst other organisms.

[object Object]

Growing community of inventors

Fermoy, Ireland

Mary Rea